Antihypertensive AgentsHypertensionBlood PressureHydrochlorothiazideDiureticsAtenololAngiotensin-Converting Enzyme InhibitorsAmlodipineCalcium Channel BlockersHydralazineMethyldopaSodium Chloride Symporter InhibitorsAdrenergic beta-AntagonistsMinoxidilBendroflumethiazideRats, Inbred SHRDoxazosinAngiotensin II Type 1 Receptor BlockersCaptoprilTetrazolesLisinoprilNordefrinGlutamyl AminopeptidaseDihydropyridinesAngiotensin Receptor AntagonistsClonidineEnalaprilIndapamideLabetalolBlood Pressure Monitoring, AmbulatoryDrug Therapy, CombinationGuanfacinePerindoprilHypertension, RenalBlood Pressure DeterminationRenin-Angiotensin SystemBenzimidazolesNifedipineImidazoline ReceptorsHeart RatePropanolaminesTreatment OutcomeDiltiazemLosartanReninPrazosinRats, Inbred WKYDouble-Blind MethodChlorthalidonePatient ComplianceAdrenergic alpha-AntagonistsFumaratesSystoleBiphenyl CompoundsDose-Response Relationship, DrugMedication AdherenceImidazolesPropranololClinical Trials as TopicValineDesoxycorticosteroneHypertension, RenovascularKidney Failure, ChronicKidneyTime FactorsPhenylacetatesRisk FactorsDrug CombinationsDiabetic NephropathiesBenzopyransFollow-Up StudiesCardiovascular DiseasesHemodynamicsProteinuriaTrichlormethiazideProspective StudiesArteriesDelayed-Action PreparationsCardiovascular SystemDiabetes Mellitus, Type 2Diabetes ComplicationsAdministration, OralRandomized Controlled Trials as TopicThiazidesAmidesKidney DiseasesVasodilator AgentsAortaHistocompatibility Antigens Class ICreatinineHistocompatibility Antigens Class IIBenzothiadiazinesSympathetic Nervous SystemRisk AssessmentRetrospective StudiesHypertrophy, Left VentricularStrokeFelodipineRamiprilCilazapril